Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

STRATA Skin Sciences (SSKN) EBT Margin (2016 - 2025)

Historic EBT Margin for STRATA Skin Sciences (SSKN) over the last 13 years, with Q3 2025 value amounting to 23.41%.

  • STRATA Skin Sciences' EBT Margin rose 1700.0% to 23.41% in Q3 2025 from the same period last year, while for Sep 2025 it was 36.37%, marking a year-over-year decrease of 48800.0%. This contributed to the annual value of 30.56% for FY2024, which is 21800.0% up from last year.
  • As of Q3 2025, STRATA Skin Sciences' EBT Margin stood at 23.41%, which was up 1700.0% from 32.48% recorded in Q2 2025.
  • STRATA Skin Sciences' 5-year EBT Margin high stood at 14.71% for Q2 2021, and its period low was 49.87% during Q1 2024.
  • Moreover, its 5-year median value for EBT Margin was 23.58% (2024), whereas its average is 24.07%.
  • Per our database at Business Quant, STRATA Skin Sciences' EBT Margin skyrocketed by 552300bps in 2021 and then tumbled by -438100bps in 2023.
  • Quarter analysis of 5 years shows STRATA Skin Sciences' EBT Margin stood at 9.13% in 2021, then surged by 90bps to 0.91% in 2022, then crashed by -4788bps to 44.72% in 2023, then fell by -10bps to 49.34% in 2024, then soared by 53bps to 23.41% in 2025.
  • Its EBT Margin was 23.41% in Q3 2025, compared to 32.48% in Q2 2025 and 35.7% in Q1 2025.